en · de · es · fr · pt
sr9009-notes.peptides4088.com › Guide › Background And Receptor Mechanism — Beginner to Advanced

Background And Receptor Mechanism — Beginner to Advanced

By Editorial Desk · published 2026-01-24 · last reviewed 2026-03-17 · Guide

If you have been reading about freeze-thaw and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Last reviewed on 2026-03-17. Where a claim depends on a specific study, the study is described rather than over-claimed.

Background and Receptor Mechanism

At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.

Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.

Background and Pharmacological Mechanism

SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.

Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.

SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.

Sr9009 at a glance

PropertyValueNotes
Chemical classSynthetic small moleculeStudied as a REV-ERB agonist
Molecular formulaC20H24ClN3O4SReported for the neutral compound
AppearanceOff-white to pale yellow solidTypical research-grade material
SolubilitySparingly soluble in waterSoluble in solvents such as DMSO
Common synonymsSR9009; StenabolicStenabolic is an informal alias

SR9009 Identity and Mechanism

REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.

SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.

SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.

Related pages on this site

Analytical and Handling Considerations

For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.

Laboratory identification of SR9009 typically relies on chromatographic separation coupled to mass spectrometry, often with ultraviolet detection as a secondary check. Nuclear magnetic resonance spectroscopy can confirm molecular structure when a reference standard is available. Because many suppliers sell the compound as a research chemical, independent identity testing is important for experimental reproducibility. A single retention time is not sufficient proof of identity, especially when related compounds may be present. Purity assessments usually report a percentage based on area normalization.

SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.

Background from the literature

=== Pavlopetri === Ceramic petrography has also been used in underwater locations, where excavations and analysis of remains can prove far more challenging. For example, in the submerged city of Pavlopetri (C. 3500 – 1500BCE) scientists have used petrography to examine the mineralogical make-up and microstructure of underwater pottery, allowing archaeologists to gain an insight into the trade routes, production methods, and various other cultural practices that the inhabitants of Pavlopetri adopted. From this analysis, scholars have been able to link Pavlopetri to trade in Minoan Crete.

UPS Flight Forward is a subsidiary which was formed in July 2019 and approved by FAA for Part 135 Standard certification, first ever to receive this specific type of certification. The FAA's Part 135 Standard certification allows company to operate an unlimited number of drones of any size (even allowing the cargo to exceed 55 pounds) even with an unlimited number of remote operators in command.

The best-known classical dance is Bharatanatyam, which began as temple dances performed by Tamil devadasis. Identified with "prostitutes and courtesans", their dancing was formally banned in 1947. Concurrently, the dance was rehabilitated as a "pure" art form, with Rukmini Devi Arundale as a prominent figure. A devdasi who went on to attain national and international prominence was Thanjavur Balasaraswati. Some sources consider the dance-dramas Chhau of Jharkhand, West Bengal, and Odisha and Yakshagana of Karnataka to also belong to the classical tradition. Local dance traditions vary widely across India. In addition to the dance-dramas Chhau and Yakshagana, they include dance-dramas Raslila of western Uttar Pradesh and Terukkuttu of Tamil Nadu; calendrical and festival dances such as the Bhangra of Punjab, especially at Vaisakhi, the onset of spring, and Garba of Gujarat during Navratri; and tribal or Adivasi dances, such as those of the Santal and Toda people, the latter, for example, in honour of the god Ön who brought buffalo to earth. Among 20th-century directions is the modern dance of Uday Shankar in which classical styles were employed but not adhered to rigidly. Examples are dance-dramas based on the ancient Indian animal fables, Panchatantra, and Nehru's mid-century meditation on Indian history, The Discovery of India. Dance has been an essential aspect of Indian films from the first talkies of the 1930s. Individual and group dances in Bollywood, for example, show a broad range of influences, including classical, local, and Western popular dance.

Sources: en.wikipedia.org

Reference notes

The new tools of molecular biology changed the study of bird systematics, which changed from being based on phenotype to the underlying genotype. The use of techniques such as DNA–DNA hybridization to study evolutionary relationships was pioneered by Charles Sibley and Jon Edward Ahlquist, resulting in what is called the Sibley–Ahlquist taxonomy. These early techniques have been replaced by newer ones based on mitochondrial DNA sequences and molecular phylogenetics approaches that make use of computational procedures for sequence alignment, construction of phylogenetic trees, and calibration of molecular clocks to infer evolutionary relationships. Molecular techniques are also widely used in studies of avian population biology and ecology.

== Comorbidity == Diabetes patients' comorbidities have a significant impact on medical expenses and related costs. It has been demonstrated that patients with diabetes are more likely to experience respiratory, urinary tract, and skin infections, develop atherosclerosis, hypertension, and chronic kidney disease, putting them at increased risk of infection and complications that require medical attention. Patients with diabetes mellitus are more likely to experience certain infections, such as COVID-19, with prevalence rates ranging from 5.3 to 35.5%. Maintaining adequate glycemic control is the primary goal of diabetes management since it is critical to managing diabetes and preventing or postponing such complications. People with type 1 diabetes have higher rates of autoimmune disorders than the general population. An analysis of a type 1 diabetes registry found that 27% of the 25,000 participants had other autoimmune disorders. Between 2% and 16% of people with type 1 diabetes also have celiac disease.

In the wild they inhabit very soft, acidic waters (pH 4.0 to 4.8) Ideal pH for aquarium is 7.0, but a range of 6.0 to 8.0 is tolerable. They can have a lifespan of as long as ten years, but normally just two to three years in an aquarium. Neon tetras are considered easy to keep in an aquarium of at least 10 US gallons (38 L; 8.3 imp gal) with a temperature range of between 72–76 °F (22–24 °C), a water pH of between 6.0 and 7.0, GH of below 10 dGH and KH of 1–2 dKH, and under 20 ppm of nitrate. They are shoaling fish and must be kept in groups of at least six, but will be more active in groups of eight to 12 or more. Neon tetras are best kept in a densely planted tank to resemble their native Amazon environments.

Elizabeth Evans Hughes Gossett (August 19, 1907 – April 21, 1981), the daughter of statesman Charles Evans Hughes, was the first American, and one of the first people in the world, treated with insulin for type 1 diabetes. She received over 42,000 insulin shots over her lifetime.

Sources: en.wikipedia.org

Notes from published material

The Marxist–Leninist worldview is atheist, wherein all human activity results from human volition and not the will of supernatural beings (gods, goddesses and demons) who have direct agency in the public and private affairs of human society. The tenets of the Soviet Union's national policy of Marxist–Leninist atheism originated from the philosophies of Georg Wilhelm Friedrich Hegel (1770–1831) and Ludwig Feuerbach (1804–1872) as well as that of Karl Marx (1818–1883) and Vladimir Lenin (1870–1924). As a basis of Marxism–Leninism, the philosophy of materialism (the physical universe exists independently of human consciousness) is applied as dialectical materialism (considered by its proponents a philosophy of science, history and nature) to examine the socio-economic relations among people and things as parts of a dynamic, material world that is unlike the immaterial world of metaphysics. Soviet astrophysicist Vitaly Ginzburg said that ideologically the "Bolshevik communists were not merely atheists, but, according to Lenin's terminology, militant atheists" in excluding religion from the social mainstream, from education and from government.

The total amount of water in the body needs to be kept in balance. Fluid balance involves keeping the fluid volume stabilized, and also keeping the levels of electrolytes in the extracellular fluid stable. Fluid balance is maintained by the process of osmoregulation and by behavior. Osmotic pressure is detected by osmoreceptors in the median preoptic nucleus in the hypothalamus. Measurement of the plasma osmolality to give an indication of the water content of the body, relies on the fact that water losses from the body, (through unavoidable water loss through the skin which is not entirely waterproof and therefore always slightly moist, water vapor in the exhaled air, sweating, vomiting, normal feces and especially diarrhea) are all hypotonic, meaning that they are less salty than the body fluids (compare, for instance, the taste of saliva with that of tears. The latter has almost the same salt content as the extracellular fluid, whereas the former is hypotonic with respect to the plasma. Saliva does not taste salty, whereas tears are decidedly salty). Nearly all normal and abnormal losses of body water therefore cause the extracellular fluid to become hypertonic. Conversely, excessive fluid intake dilutes the extracellular fluid causing the hypothalamus to register hypotonic hyponatremia conditions. When the hypothalamus detects a hypertonic extracellular environment, it causes the secretion of an antidiuretic hormone (ADH) called vasopressin which acts on the effector organ, which in this case is the kidney.

=== Reston virus: monkeys with ebola virus brought to U.S. === In December 1989, several crab-eating macaques with the Zaire ebolavirus were imported from Mindanao in the Philippines to the company's facility in Reston, Virginia. The strain of the virus became known as the Reston virus. It was the first ebola virus that emerged outside of Africa and was also the first known natural infection of ebola virus in nonhuman primates. The facility was abandoned and torn down and the variant turned out to be non-lethal to humans. The incident was an inspiration for The Hot Zone, a book by Richard Preston published in 1994. In March 1996, two macaques that had been shipped to the company's facility in Alice, Texas, tested positive for the Ebola virus from a group of 100 obtained from the same supplier. The virus strain was the same non-lethal Reston virus as in the earlier incident.

In immunocytochemistry experiments, one (polyclonal) antibody against CSP labeled the antennal sensillum, but the labeling was not restricted to sensory structures but rather diffused to the cuticle and supporting cells [3, 36]. A function of CSPs in lipid transport is consistent with a crucial role not only in insect general immunity, moth pheromone synthesis or locust behavioral phase change, but also in head development as described in honeybees [37]. CSPs have been proposed to mediate recognition of chemical signatures composed of cuticular lipids as for instance in ants [38]. However, it is not clear whether some CSPs are involved in chemical communications, others in development or other physiological roles. The functional CSP structure is bound with fatty acid molecules [5]. Other functional CSP structures have been shown to interact directly with exogenous compounds such as toxic chemical compounds (cinnamaldehyde) from plant oils [34]. So, CSPs expressed not only in arthropods, but also in bacteria, and apparently endowed with heterogeneous functions. CSPs can trigger innate immune pathways in plants [39].

=== Double bond position === Each cannabinoid may exist in different forms depending on the double bond position in the alicyclic carbon ring. Under the dibenzopyran numbering system, the major form of THC is Δ9-THC, and the minor form is Δ8-THC. In the alternate terpene numbering system, these are Δ1-THC and Δ6-THC, respectively.

Sources: en.wikipedia.org

Frequently asked questions

What is SR9009?

SR9009 is a synthetic research compound that activates the REV-ERBα and REV-ERBβ nuclear receptors. It is not an approved drug and has no established human therapeutic use. Most published biological data come from cell and rodent studies.

Is SR9009 a SARM?

No. SR9009 is frequently mislabeled as a SARM in online discussions, but it does not target androgen receptors. Its known mechanism involves REV-ERB nuclear receptors and circadian-metabolic gene regulation.

What human data exist for SR9009?

Human clinical data are very limited. There is no approved human use, and safety and efficacy in people are not established. Most evidence comes from preclinical models, so effects observed in animals may not apply to humans.

What is SR9009?

It is a synthetic REV-ERB agonist used mainly in preclinical research. It is not an approved medicine for human use.

Network